Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Fig 1.

Selection of the study population.

More »

Fig 1 Expand

Fig 2.

Overview on the five regions.

More »

Fig 2 Expand

Fig 3.

Percentage of 40–69 year old men without cardiovascular diseases with low, moderate and high 10-year CVD mortality risk* *low risk: SCORE<1%; moderate risk: SCORE 1-<5%; high risk: SCORE≥5% and/or any of the risk factors (diabetes, renal insufficiency, stage 3 hypertension or total cholesterol ≥ 8 mmol/l).

More »

Fig 3 Expand

Fig 4.

Percentage of 40–69 year old women without cardiovascular diseases with low, moderate and high risk 10-year CVD mortality risk* *low risk: SCORE<1%; moderate risk: SCORE 1-<5%; high risk: SCORE≥5% and/or any of the risk factors (diabetes, renal insufficiency, stage 3 hypertension or total cholesterol ≥ 8 mmol/l).

More »

Fig 4 Expand

Table 1.

Characteristics of the 40–69 year old study population without cardiovascular diseases (n = 3,498, % are weighted population estimates).

More »

Table 1 Expand

Table 2.

Percentage of 40–69 year old men without cardiovascular diseases with a high 10-year CVD mortality risk* according to SES, region and community size.

More »

Table 2 Expand

Table 3.

Percentage of 40–69 year old women without cardiovascular diseases with a high 10-year CVD mortality risk* according to SES, region and community size.

More »

Table 3 Expand

Fig 5.

Contribution of single risk factors* to the high risk group in 40–69 year old men and women without cardiovascular diseases *Stepwise definition of the high risk group: First of all, the percentage of individuals with a SCORE ≥ 5% (including individuals with diabetes and other risk factors) were calculated, then the percentage of individuals with diabetes and finally, the percentage of individuals with any of the remaining risk factors (renal insufficiency, stage 3 hypertension or total cholesterol ≥ 8 mmol/l).

More »

Fig 5 Expand